Jan Stevang
University of Copenhagen, Denmark
Biography
Jan Stenvang has completed his PhD in 2003 from the University of Copenhagen. He has worked as group leader in both academia and biotech. Currently, he is Associate Professor in a translational research group focusing on resistance to chemotherapy, and implementation of research into clinical trials. He has published 46 publications in peer-reviewed journals and has 2 patents.
Abstract
Abstract : Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines